Genetische Befunde bei der Aufmerksamkeitsdefizit- und Hyperaktivitätsstörung (ADHS)
Abstract
Zusammenfassung: Die Aufmerksamkeitsdefizit- und Hyperaktivitätsstörung (ADHS) ist mit einer Prävalenz von 3-7% eine häufige kinder- und jugendpsychiatrische Störung. Auf der Basis formalgenetischer Studien ergibt sich eine Heritabilitätsschätzung von 60-80% für ADHS mit einem ca. 5-fach erhöhten Risiko für erstgradige Verwandte von Betroffenen. Bislang vier Genomscans lieferten potentiell relevante chromosomale Regionen, insbesondere den einheitlichen Kopplungsbefund auf 5p13. Aus einer Vielzahl von Assoziationsstudien zu Kandidatengenen deuten aktuelle Metaanalysen auf die Relevanz der Gene der dopaminergen Rezeptoren DRD4 und DRD5 sowie des serotonergen Rezeptors HTR1B und des Synaptosomal Assoziierten Proteins (SNAP-25). In Tiermodellen liegen vorwiegend Paradigmen für Hyperaktivität vor; diese sind in knockout- und Quantitative Trait Loci (QTL) Designs mit viel versprechenden Ergebnissen zum dopaminergen System untersucht worden. Es ist davon auszugehen, dass erst das Zusammenwirken verschiedener Gen-Varianten mit jeweils moderatem bis hin zu kleinem Effekt den Phänotyp ADHS bedingen (Oligo-/ Polygenie) und bei verschiedenen Betroffenen unterschiedliche Kombinationen von prädisponierenden Gen-Polymorphismen zu ADHS führen können. Entsprechend sind für molekulargenetische Studien große Fallzahlen notwendig und die bisherigen Befunde als vorläufig zu interpretieren. Zukunftsweisend für die molekulargenetische Aufklärung von ADHS sind SNP-basierte Genomscans, mit denen 10 000-1 000 000 einzelne Polymorphismen (SNPs) gleichzeitig untersucht werden können. Tiermodelle liefern Hinweise auf die Funktion relevanter Kandidatengene und tragen zur Erweiterung der bislang teilweise widersprüchlichen Kenntnisse zur Neurobiologie des ADHS bei.
Summary: Attention-Deficit and Hyperactivity Disorder (ADHD) is a common child and adolescent psychiatric disorder with a prevalence rate of 3-7%. Formal genetic studies provided an estimated heritability of 0.6-0.8 and an approximately five-fold elevated risk for ADHD in first-degree relatives. Currently, four genome scans have led to the identification of chromosomal regions potentially relevant in ADHD; especially the evidence for linkage to chromosome 5p13 is convincing. Meta-analyses of a large number of candidate gene studies suggest association with gene variants of the dopaminergic receptors DRD4 and DRD5, the serotonergic receptor HTR1B, and the synaptosomal receptor protein (SNAP-25). Hyperactivity has been investigated particularly in animal models, focusing on knockout- and quantitative trait loci (QTL) designs, with promising results for the dopaminergic system. It is likely that several gene polymorphisms with moderate to small effect sizes contribute to the phenotype ADHD; different combinations of such predisposing variants presumably underlie ADHD in different individuals. Therefore, large samples for molecular genetic studies are mandatory to detect these polymorphisms. Accordingly, several of today’s findings have to be regarded as preliminary. The understanding of ADHD’s neurobiology may be advanced by new technologies, such as SNP-based genome scans performed with gene chips comprising 10,000-1,000,000 SNPs, as well as using more sophisticated animal model designs.
Literatur
1996). A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proceedings of the National Academy of Science USA, 93, 1945– 1949
(1994). Diagnostic Criteria from DSM-IV. Washington, DC: American Psychiatric Press
(2003). A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders.. Molecular Psychiatry, 8, (6) 574– 59
(2004). Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. American Journal of Human Genetics, 75, 998– 1014
(1995). Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377, 424– 428
(2003). A Whole-Genome Scan in 164 Dutch Sib Pairs with Attention-Deficit/Hyperactivity Disorder: Suggestive Evidence for Linkage on Chromosomes 7p and 15q. American Journal of Human Genetics, 72, 1251– 1260
(2006). Lack of significant association between -1021C—>T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neuroscience Letter, 402, (1-2) 12– 16
(1992). Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Archives of General Psychiatry, 49, 728– 738
(2006). Meta-analysis of Association Between a Catechol-O-Methyltransferase Gene Polymorphism and Attention Deficit Hyperactivity Disorder. Behavioral Genetics, (Epub ahead of print)
(2005). The serotonin transporter gene as a QTL for ADHD. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 134b, 42– 47
(2005). Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 134, (1) 110– 114
(1995). The transmission/disequilibrium test: history, subdivision, and admixture. American Journal of Human Genetics, 57, (2) 455– 464
(2002). Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. European Journal of Neuroscience, 15, 158– 164
(2000). Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective. Journal of the American Academy of Child and Adolescent Psychiatry, 39, (3) 300– 307
(2001). The nature and heritability of attentiondeficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North Americaca, 10, (2) 299– 316
(2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, (11) 1313– 1323
(2002). A genome-wide scan for loci involved in attention-deficit/hyperactivity disorder. American Journal of Human Genetics, 70, 1183– 1196
(2005). Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 132, (1) 96– 99
(1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606– 612
(1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Science USA, 95, 9991– 9996
(1989). A twin study of hyperactivity-II. The aetiological role of genes, family relationships and perinatal adversity. Journal of Child Psychology and Psychiatry, 30, (5) 691– 709
(2001). Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population. Molecular Psychiatry, 6, (4) 420– 424
(2005). Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. American Journal of Human Genetics, 77, (6) 958– 965
(2006). A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Molecular Psychiatry, 11, (2) 196– 205
(2004). Molecular genetic aspects of attention-deficit/hyperactivity disorder. Neuroscience Biobehavioral Reviews, 28, (6 625– 641
(2001). Behavioral characterization of dopamine D5 receptor null mutant mice. Behavioral Neuroscience, 115, 1129– 1144
(2002). Effect of Dopamine Uptake Inhibition on Brain Catecholamine Levels and Locomotion in Catechol-O-methyltransferase-Disrupted Mice. Journal of Pharmacology and Experimental Therapeutics, 303, 1309– 1316
(2002). Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Molecular Psychiatry, 7, 908– 912
(2005). Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Molecular Psychiatry, 10, (10) 939– 943
(2006). Family-based designs in the age of large-scale gene-association studies. Nature Reviews. Genetics, 7, (5– 385 394
(1998). Attention-deficit hyperactivity disorder subtypes and comorbid disruptive behaviour disorders in a child and adolescent mental health clinic. Canadian Journal of Psychiatry, 43, (6 623– 628
(1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics, 1, 241– 247
(2003). No evidence of association of two 5HT transporter gene polymorphisms and attention deficit hyperactivity disorder. Psychiatric Genetics, 13, 107– 110
(2005). Gender differences in ADHD subtype comorbidity. Journal of the American Academy of Child and Adolescent Psychiatry, 44, (4) 368– 376
(2006a). Metaanalysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Human Molecular Genetics, 15, (14) 2276– 2284
(2006b). Contribution of 5-HT2A receptor gene -1438A>G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 141, (5)– 473– 476
(2006c). Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 141, (2) 126– 129
(2005). The dopamine transporter and attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, (11) 1397– 1409
(2001). Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics, 105, 91– 95
(2002). Observer effects and heritability of childhood attention-deficit hyperactivity disorder symptoms. British Journal of Psychiatry, 180, 260– 265
(1996). A major quantitative trait locus influences hyperactivity in the WKHA rat. Nature Genetics, 14, 471– 473
(1998). Significance levels in complex inheritance. American Journal of Human Genetics, 62, 690– 697
(1998). Behavior in mice with targeted disruption of single genes. Neuroscience Biobehavior Reviews, 22, 453– 462
(2005). Estimation of prevalence of DSM-IV and latent class-defined ADHD subtypes in a population-based sample of child and adolescent twins. Twin Research Human Genetics, 8, (4) 392– 401
(2004). Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. American Journal of Human Genetics, 75, (4) 661– 668
(2003). A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. American Journal of Human Genetics, 72, (5) 1268– 1279
(2006). Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Molecular Psychiatry, 11, (1) 5– 8
(2005). Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology, 30, (10) 1818– 1831
(1997). Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell, 90, 991– 1001
(1994). Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science, 265, 1875– 1878
(2006). Association Between Alpha-2a-adrenergic Receptor Gene and ADHD Inattentive Type. Biological Psychiatry, Jun 23 (Epub ahead of print)
(2001). Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Molecular Psychiatry, 6, 235– 238
(2000). Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, (9) 1135– 1143
(2003). Formalgenetische Befunde zur Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Fortschritte der Neurologie und Psychiatrie, 71, (7) 366– 377
(2006). Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. CNS Neurological Disordisorders Drug Targets, 5, (1) 45– 56
(2000). Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behavioral Pharmacology, 11, 279– 290
(2006). A QTL on rat chromosome 7 modulates prepulse inhibition, a neuro behavioral trait of ADHD, in a Lewis x SHR intercross. Behavioral and Brain Functions, 2, (1 21–
(2005). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Molecular Psychiatry, 10, (12) 1126– 1132
(2002). Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proceedings of the National Academy of Science USA, 99, 13873– 13877
(2003). The math of making mutant mice. Genes, Brain, and Behavior, 2, 191– 200
(1994). Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell, 79, 945– 955
(2002). Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology, 45, 176– 181
(